Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
42385-929 -
Package NDC
42385-929-18 -
Package NDC
42385-929-30 -
Package NDC
42385-929-31 -
Package NDC
42385-929-82 -
Package NDC
42385-929-90 -
Package NDC
42385-929-91 -
Application number
ANDA213038 -
SPL ID
80228c3a-152e-4170-9469-b4e13b137bcb -
SPL set ID
98342153-b9de-4318-aac4-9f8d19590cd7 -
UNII
JE6H2O27P8 -
UNII
2T8Q726O95 -
UNII
OTT9J7900I -
RxCUI
2001424
What the source publishes
- Labeler
- Laurus Labs Limited
- Active ingredients
- Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
- Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
- EFAVIRENZ
- LAMIVUDINE
- TENOFOVIR DISOPROXIL FUMARATE
Complete source data
{
"name": "Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate",
"splId": "80228c3a-152e-4170-9469-b4e13b137bcb",
"labels": [
{
"setId": "98342153-b9de-4318-aac4-9f8d19590cd7",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=98342153-b9de-4318-aac4-9f8d19590cd7",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=98342153-b9de-4318-aac4-9f8d19590cd7"
}
],
"routes": [
"ORAL"
],
"labeler": "Laurus Labs Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "180 TABLET, FILM COATED in 1 BOTTLE (42385-929-18)",
"package_ndc": "42385-929-18",
"identifierStatus": "well-formed",
"marketing_start_date": "20200514"
},
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (42385-929-30)",
"package_ndc": "42385-929-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20200514"
},
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (42385-929-31)",
"package_ndc": "42385-929-31",
"identifierStatus": "well-formed",
"marketing_start_date": "20200514"
},
{
"sample": false,
"description": "180 TABLET, FILM COATED in 1 BOTTLE (42385-929-82)",
"package_ndc": "42385-929-82",
"identifierStatus": "well-formed",
"marketing_start_date": "20200514"
},
{
"sample": false,
"description": "90 TABLET, FILM COATED in 1 BOTTLE (42385-929-90)",
"package_ndc": "42385-929-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20200514"
},
{
"sample": false,
"description": "90 TABLET, FILM COATED in 1 BOTTLE (42385-929-91)",
"package_ndc": "42385-929-91",
"identifierStatus": "well-formed",
"marketing_start_date": "20200514"
}
],
"productId": "42385-929_80228c3a-152e-4170-9469-b4e13b137bcb",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "42385-929",
"deaSchedule": null,
"genericName": "Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "EFAVIRENZ",
"strength": "400 mg/1"
},
{
"name": "LAMIVUDINE",
"strength": "300 mg/1"
},
{
"name": "TENOFOVIR DISOPROXIL FUMARATE",
"strength": "300 mg/1"
}
],
"applicationNumber": "ANDA213038",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200514",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175463",
"N0000175460",
"N0000009948",
"N0000190118",
"N0000187064",
"N0000185504",
"N0000182140",
"N0000182141",
"N0000175656",
"N0000175462",
"N0000009947"
],
"upc": [
"0342385929317"
],
"unii": [
"JE6H2O27P8",
"2T8Q726O95",
"OTT9J7900I"
],
"rxcui": [
"2001424"
],
"spl_set_id": [
"98342153-b9de-4318-aac4-9f8d19590cd7"
],
"pharm_class_epc": [
"Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
"Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
"Cytochrome P450 3A Inducers [MoA]",
"Cytochrome P450 2B6 Inducers [MoA]",
"Cytochrome P450 2C9 Inhibitors [MoA]",
"Cytochrome P450 2C19 Inhibitors [MoA]",
"Cytochrome P450 3A4 Inhibitors [MoA]",
"Nucleoside Reverse Transcriptase Inhibitors [MoA]"
],
"manufacturer_name": [
"Laurus Labs Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:42385-929_80228c3a-152e-4170-9469-b4e13b137bcb"